19 March 2010 - Psychiatric News - Omega-3s May Have Ability to Delay or Prevent Psychosis
FAB RESEARCH COMMENT:
The long-chain omega-3 fatty acids found in fish and seafood (called EPA and DHA) have long been known to have benefits for general health, reducing the risk of cardiovascular disease - which is higher in patients with schizophrenia than in the general population.
In this study (a randomised, double-blind, placebo-controlled trial), supplementation with fish oils providing 1.2 grams / day for just 12 weeks was found to protect against the emergence of schizophrenia for 12 months in young people who were judged to be at high risk of developing this illness.
See also: Fish Oil Supplements 'beat psychotic mental illness'
Supplements of omega-3 fatty acids have now been deployed against some of the most formidable psychiatric illnesses—psychotic disorders—and initial results are encouraging.
Suppose you gave omega-3 fatty acids to a patient in the prodromal phase of schizophrenia. Could the supplement keep the illness from developing further? Quite possibly, a study reported in the February Archives of General Psychiatry suggests.
Food and Behaviour Research is a registered charity (No SC034604) and a company limited by guarantee (Co No SC 253448)
Newsletter Signup
Useful Links
Contact Us
FAB Research
23 Carlton Road
Oxford
OX2 7SA
Important Notice
Medical opinion and guidance should always be sought for any symptoms that might possibly reflect a known or suspected disease, disorder or medical condition. Information provided on this website (or by FAB Research via any other means) does not in any way constitute advice on the treatment of any medical condition formally diagnosed or otherwise.
Site by Redstone Websites. Easy to Use Web Content Management. 2023 © All Rights Reserved.